The shifting interface between IBS and IBD

Current Opinion in Pharmacology

Volumn 11, Issue 6, 2011, Pages 586-592

  Spiller, Robin ^a   Lam, Ching ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA DEFENSIN; MESALAZINE; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR;

ARTICLE; BIFIDOBACTERIUM LONGUM; CAMPYLOBACTER ENTERITIS; CELL ACTIVATION; CROHN DISEASE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG USE; ENTERITIS; FAECALIBACTERIUM PRAUSNTZII; FIRMICUTES; GASTROENTERITIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LIFE STRESS; MAST CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSOCIAL CARE; RISK FACTOR; SMALL INTESTINE DISEASE; STREPTOCOCCUS THERMOPHILUS; SYMPTOM;

EID: 82255192437     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.09.009     Document Type: Review

References (45)

1. J.C. Barrett, S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, J.D. Rioux, S.R. Brant, M.S. Silverberg, K.D. Taylor, and M.M. Barmada Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 40 2008 955 962
2. M. Zucchelli, M. Camilleri, A.A. Nixon, F. Bresso, A. Dlugosz, J. Halfvarson, L. Torkvist, P.T. Schmidt, P. Karling, and B. Ohlsson Association of TNFSF15 polymorphism with irritable bowel syndrome Gut 2011
3. A.C. Villani, M. Lemire, M. Thabane, A. Belisle, G. Geneau, A.X. Garg, W.F. Clark, P. Moayyedi, S.M. Collins, and D. Franchimont Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis Gastroenterology 138 2010 1502 1513
4. K.O. Gradel, H.L. Nielsen, H.C. Schonheyder, T. Ejlertsen, B. Kristensen, and H. Nielsen Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis Gastroenterology 137 2009 495 501
5. C.R. Hedin, A.J. Stagg, K. Whelan, and J.O. Lindsay Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention Gut 2011
6. C.K. Porter, K. Gloor, B.D. Cash, and M.S. Riddle Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment Dig Dis Sci 2011 (online)
7. Q. Zhou, B. Zhang, and G.N. Verne Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome Pain 146 2009 41 46
8. Q. Zhou, W.W. Souba, C.M. Croce, and G.N. Verne MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome Gut 59 2010 775 784
9. T. Piche, G. Barbara, P. Aubert, V. Bruley d, R. Dainese, J.L. Nano, C. Cremon, V. Stanghellini, G.R. De, and J.P. Galmiche Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators Gut 58 2009 196 201
10. J. Zeng, Y.Q. Li, X.L. Zuo, Y.B. Zhen, J. Yang, and C.H. Liu Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 28 2008 994 1002
11. S. Buhner, Q. Li, S. Vignali, G. Barbara, G.R. De, V. Stanghellini, C. Cremon, F. Zeller, R. Langer, and H. Daniel Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome Gastroenterology 137 2009 1425 1434
12. K. Gecse, R. Roka, L. Ferrier, M. Leveque, H. Eutamene, C. Cartier, A. it-Belgnaoui, A. Rosztoczy, F. Izbeki, and J. Fioramonti Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic luminal factor impairing colonic permeability and sensitivity Gut 57 2008 591 599
13. J.W. Lee, J.H. Park, D.I. Park, J.H. Park, H.J. Kim, Y.K. Cho, C.I. Sohn, W.K. Jeon, and B.I. Kim Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase Dig Dis Sci 55 2010 2922 2928
14. N. Wang, H. Yu, J. Ma, W. Wu, D. Zhao, X. Shi, H. Tian, and H. Jiang Evidence for tight junction protein disruption in intestinal mucosa of malignant obstructive jaundice patients Scand J Gastroenterol 45 2010 191 199
15. S.F. Assimakopoulos, A.C. Tsamandas, E. Louvros, C.E. Vagianos, V.N. Nikolopoulou, K.C. Thomopoulos, A. Charonis, and C.D. Scopa Intestinal epithelial cell proliferation, apoptosis and expression of tight junction proteins in patients with obstructive jaundice Eur J Clin Invest 41 2011 117 125
16. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, S. Murzilli, L.W. Klomp, P.D. Siersema, M.E. Schipper, and S. Danese Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 60 2011 463 472
17. S. Singh, L.A. Graff, and C.N. Bernstein Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol 104 2009 1298 1313
18. R. Spiller, and K. Garsed Postinfectious irritable bowel syndrome Gastroenterology 136 2009 1979 1988
19. C.N. Bernstein, S. Singh, L.A. Graff, J.R. Walker, N. Miller, and M. Cheang A prospective population-based study of triggers of symptomatic flares in IBD Am J Gastroenterol 105 2010 1994 2002
20. M. Vicario, M. Guilarte, C. Alonso, P. Yang, C. Martinez, L. Ramos, B. Lobo, A. Gonzalez, M. Guila, and M. Pigrau Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress Brain Behav Immun 24 2010 1166 1175
21. C. Cremon, L. Gargano, A.M. Morselli-Labate, D. Santini, R.F. Cogliandro, G.R. De, V. Stanghellini, R. Corinaldesi, and G. Barbara Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms Am J Gastroenterol 104 2009 392 400
22. T. Piche, M.C. Saint-Paul, R. Dainese, E. Marine-Barjoan, A. Iannelli, M.L. Montoya, J.F. Peyron, D. Czerucka, F. Cherikh, and J. Filippi Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome Gut 57 2008 468 473 (Pubitemid 351442529)
23. S. Foley, K. Garsed, G. Singh, N.P. Duroudier, C. Swan, I.P. Hall, A. Zaitoun, A. Bennett, C. Marsden, and G. Holmes Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation Gastroenterology 2011 (online)
24. T.K. Klooker, K.E.M. Koopman, S. Heide, R.M. Wijngaard, and G.E. Boeckxstaens Treatment with the mast cell stabilizer ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in IBS patients Gut 59 2010 1213 1221
25. M.J. Hamilton, M.J. Sinnamon, G.D. Lyng, J.N. Glickman, X. Wang, W. Xing, S.A. Krilis, R.S. Blumberg, R. Adachi, and D.M. Lee Essential role for mast cell tryptase in acute experimental colitis Proc Natl Acad Sci U S A 108 2011 290 295
26. R. Corinaldesi, V. Stanghellini, C. Cremon, L. Gargano, R.F. Cogliandro, G.R. De, G. Bartesaghi, B. Canovi, and G. Barbara Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof of concept study Aliment Pharmacol Ther 2009
27. E. Cario Toll-like receptors in inflammatory bowel diseases: a decade later Inflamm Bowel Dis 16 2010 1583 1597
28. E.K. Brint, J. Macsharry, A. Fanning, F. Shanahan, and E.M.M. Quigley Differential expression of toll-like receptors in patients with irritable bowel syndrome Am J Gastroenterol 106 2011 329 336
29. M.J. Koslowski, J. Beisner, E.F. Stange, and J. Wehkamp Innate antimicrobial host defense in small intestinal Crohn's disease Int J Med Microbiol 300 2010 34 40
30. L.A. Simms, J.D. Doecke, M.D. Walsh, N. Huang, E.V. Fowler, and G.L. Radford-Smith Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease Gut 57 2008 903 910 (Pubitemid 351919524)
31. G. Perminow, J. Beisner, M. Koslowski, L.G. Lyckander, E. Stange, M.H. Vatn, and J. Wehkamp Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease Am J Gastroenterol 105 2010 452 459
32. M.C. Aldhous, C.L. Noble, and J. Satsangi Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease PLoS One 4 2009 e6285
33. M. Zilbauer, A. Jenke, G. Wenzel, J. Postberg, A. Heusch, A.D. Phillips, G. Noble-Jamieson, F. Torrente, C. Salvestrini, and R. Heuschkel Expression of human beta-defensins in children with chronic inflammatory bowel disease PLoS One 5 2010 e15389
34. J. Langhorst, A. Junge, A. Rueffer, J. Wehkamp, D. Foell, A. Michalsen, F. Musial, and G.J. Dobos Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome Am J Gastroenterol 104 2009 404 410
35. D. Moussata, M. Goetz, A. Gloeckner, M. Kerner, B. Campbell, A. Hoffman, S. Biesterfeld, B. Flourie, J.C. Saurin, and P.R. Galle Confocal laser endomicroscopy is a new imaging modality for recognition of intramucosal bacteria in inflammatory bowel disease in vivo Gut 60 2011 26 33
36. M. Joossens, G. Huys, M. Cnockaert, V. DeP, K. Verbeke, P. Rutgeerts, P. Vandamme, and S. Vermeire Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives Gut 2011
37. A. Schwiertz, M. Jacobi, J.S. Frick, M. Richter, K. Rusch, and H. Kohler Microbiota in pediatric inflammatory bowel disease J Pediatr 157 2010 240 244
38. H. Sokol, P. Seksik, J.P. Furet, O. Firmesse, I. Nion-Larmurier, L. Beaugerie, J. Cosnes, G. Corthier, P. Marteau, and J. Dore Low counts of Faecalibacterium prausnitzii in colitis microbiota Inflamm Bowel Dis 15 2009 1183 1189
39. H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L.G. Bermudez-Humaran, J.J. Gratadoux, S. Blugeon, C. Bridonneau, J.P. Furet, and G. Corthier Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc Natl Acad Sci U S A 105 2008 16731 16736
40. W. Jia, R.N. Whitehead, L. Griffiths, C. Dawson, R.H. Waring, D.B. Ramsden, J.O. Hunter, and J.A. Cole Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 310 2010 138 144
41. C. Codling, L. O'Mahony, F. Shanahan, E.M. Quigley, and J.R. Marchesi A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome Dig Dis Sci 55 2010 392 397
42. S.O. Noor, K. Ridgway, L. Scovell, E.K. Kemsley, E.K. Lund, C. Jamieson, I.T. Johnson, and A. Narbad Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota BMC Gastroenterol 10 2010 134
43. J. Keohane, C. O'Mahony, L. O'Mahony, S. O'mahony, E.M. Quigley, and F. Shanahan Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol 105 2010 1788-1789, 1794
44. A. Akbar, Y. Yiangou, P. Facer, J.R. Walters, P. Anand, and S. Ghosh Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain Gut 57 2008 923 929 (Pubitemid 351919527)
45. A. Akbar, Y. Yiangou, P. Facer, W.G. Brydon, J.R. Walters, P. Anand, and S. Ghosh Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain Gut 59 2010 767 774